Left ventricular dilatation

Parameters

Yes (n = 40)

No (n = 25)

p-value

OR

CI (95%)

Gender

Male

27 (67.5%)

15 (60%)

0.051

2.80

0.98 - 7.99

Female

13 (32.5%)

10 (40%)

0.001

19.5

2.19 - 173.5

Age range

<55 years

25 (62.5%)

13 (52%)

0.006

4.33

1.49 - 12.6

≥55 years

15 (37.5%)

12 (48%)

0.016

6.87

1.27 - 37.15

Medical history

HBP

10 (25%)

7 (28%)

0.001

5.21

1.94 - 13.99

Diabetes

10 (25%)

3 (12%)

0.004

23.33

1.99 - 273.3

Initial nephropathy

CGN

21 (52.5%)

12 (48%)

0.003

5.54

1.74 - 17.7

Hypertensive nephropathy

19 (47.5%)

10 (40%)

0.059

3.8

0.91 - 15.78

CTIN

0 (0%)

3 (12%)

-

-

-

CKD stage

GFR < 15 ml/min

33 (82.5%)

19 (76%)

0.001

4.34

1.72 - 10.96

Clinical signs

Fluid retention

28 (70%)

18 (72%)

0.029

3.11

1.10 - 8.75

TAS ≥ 160 mmHg

19 (47.5%)

12 (48%)

0.010

4.49

1.38 - 14.57

TAD ≥ 100 mmHg

12 (30%)

10 (40%)

0.180

2.14

0.59 - 7.77

Biological signs

Hb level < 8 g/dl

25 (62.5%)

14 (56%)

0.012

3.79

1.31 - 11.01

Hypocalcemia

35 (87.5%)

16 (64%)

0.000

8.02

2.73 - 23.6

Hyperphosphatemia

18 (45%)

14 (56%)

0.539

1.47

0.43 - 5.03

CRP ≥ 20 mg/l

32 (80%)

25 (100%)

0.006

3.6

1.41 - 9.61